Pancreatic Insufficiency (DBCOND0031191)

Identifiers

Synonyms
Pancreatic insufficiency / Pancreatic failure / Pancreatic insufficiency (disorder) / Insufficiency pancreatic / Exocrine pancreatic insufficiency / Pancreatic exocrine insufficiency / Exocrine pancreatic insufficiency (disorder)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Dimethicone
An ingredient used to treat dry and irritated eyes.
No drug targets
Ox bile extract
Not Annotated
No drug targets
Pancrelipase
A purified form of porcine pancreatic lipase, amylase, and protease enzymes used to treat malabsorption associated with pancreatic insufficiency resulting from cystic fibrosis and pancreatitis.
Pancrelipase lipase
A lipase used to treat pancreatic exocrine insufficiency.
Simethicone
An anti-flatulence agent used to relieve pressure, bloating, and symptoms referred to as gas.
No drug targets
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT00432861
Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosistreatment3completed
NCT01879228
Effect of Chronic Incretin-based Therapy in Cystic FibrosisotherNot Availablecompleted
NCT00705978
Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitistreatment3completed
NCT00095732
Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiencytreatment2completed
NCT00880100
Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)treatment3completed
NCT00572975
Malabsorption Blood Test:Toward a Novel Approach to Quantify SteatorrheaNo drug interventionsdiagnostic4completed
NCT00406536
Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PINo drug interventionssupportive_care2completed
NCT00513682
Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)treatment3completed
NCT01851694
Beta-cell Response to Incretin Hormones in Cystic FibrosisNo drug interventionsotherNot Availablerecruiting
NCT00763412
Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic FibrosisotherNot Availablecompleted
NCT01012908
Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutical) in Patients With Exocrine Pancreatic InsufficiencyNo drug interventionstreatment2 / 3unknown_status
NCT03279653
Pancreatic Exocrine Insufficiency After Bariatric SurgeryNo drug interventionsNot AvailableNot Availableunknown_status
NCT01144507
Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic FibrosisNo drug interventionsNot AvailableNot Availablecompleted
NCT00535756
Creon After Pancreatic Surgerytreatment4completed
NCT03551691
Proton Pump Inhibitors (PPI) and Fat Absorption in Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (EPI)treatment2completed
NCT01710644
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosistreatment1 / 2completed
NCT02979340
MRI to Characterize and Predict CF Liver Disease in PUSH CohortNo drug interventionsNot AvailableNot Availablecompleted
NCT02985801
PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancertreatment1 / 2terminated
NCT05700604
Hypoglycemia and Glucagon Response in CFNo drug interventionsNot AvailableNot Availablecompleted
NCT04731272
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intoleranceother2recruiting
NCT03450772
Equivalence Study to Compare Two Strengths of Creon in Chinatreatment3unknown_status
NCT01988350
Pancreatic Insufficiency Secondary to Tobacco ExposureNo drug interventionsNot AvailableNot Availablecompleted
NCT05466838
PERT to Improve Quality of Life in Patients Undergoing Pancreaticoduodenectomy: A Pilot Randomized Controlled TrialNo drug interventionstreatmentNot Availablerecruiting